Improved controller for clinical trials results in six-month delay
Press release 28 April, 2022 Realheart has decided to equip patients in the first clinical trial with the full version of the controller – a kind of remote control – instead of a simpler version as previously envisaged. This will benefit patients and shorten the overall development time of the controller but will delay the human trial by six months, now set to begin in the first half of 2024 instead of the second half of 2023.''Our goal is an artificial heart that allows the user to lead a good life with great freedom of movement. This also applies to the patients participating in our